🇺🇸 SECNatWest Group plcDoubao · 实盘不做把握 9/10不做原因:无增量信息
北京时间·🕒 发布 00:57:03·⟳ 抓取 00:57:22 +19s·⚡ 决策 09-12 00:59:05 +1m43s·45.8 天前
NatWest Group 披露既有回购计划下一周度回购执行明细（9月8–10日，约267.5万股），无新增授权或预期差
这是外国发行人按 UK MAR 对既有回购计划逐周/逐日交易的法定明细报备：回购授权和券商指令早在 2026-02-16 即已公告，本期只是 UBS 在 9 月 8–10 日的机械执行结果，市场在计划宣布时已定价；本周回购金额（约 1,800 万英镑量级）相对 NatWest 市值微不足道，无新增授权、上调或盈利信息，缺乏任何方向性 edge。
📄 原文NatWest Group plc↗ 原文
----- a5087u.htm ----- 6-K 1 a5087u.htm TRANSACTION IN OWN SHARES a5087u UNITED STATES SECURITIES AND EXCHANGE COMMISSI…
不做 NatWest Group plc（NWG.US）
既有回购计划（2026-02-16 公告）的周度例行执行报备，无新增授权或预期差，本周回购金额相对市值可忽略，属行政性 MAR 披露，不构成交易催化。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
SEC 6-K 内容为 NatWest 既有股票回购计划下 9 月 8–10 日约 267.5 万股的周度回购明细，回购股份将注销；该计划及对 UBS 的指令于 2026-02-16 已公告，本次仅为 UK MAR 第 5(1)(b) 条要求的例行执行披露，未包含新授权、新金额指引或超预期事项，回购规模相对公司市值可忽略。属行政性备案而非新增催化，故对 NatWest 本身及任何关联标的均无正期望交易，回避。
主要风险
- 将例行回购执行误读为新增利好而追多：计划 2 月已宣布，本期不构成增量信息。
反向证据
- 做多前查反向 · 来源 filing · 日期 2026-09-11 · 影响 invalidates
6-K 未包含任何新增/扩大回购、特别股息或超预期回报内容，仅为既有计划执行；多头无增量支撑。
检索:NatWest buyback increased enlarged programme September 2026 new authorization 原文 ↗
先例如何影响了这次决策
对本次决策的影响:无需先例：事件性质为既有计划的例行执行披露，结论由无增量事实直接决定，任何历史涨幅均不适用于此类行政性备案。
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 295 ms
{"result": "search_processed_events:agent query=`natwest group 6-k own shares purchase cancellation | natwest group transaction in own shares buyback september 2026 | natwest nwg share repurchase ubs weekly september 8-10 2026`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 39.2/72 小时、920 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agen
原文全文
展开原文 · 3,440 字
----- a5087u.htm -----
6-K
1
a5087u.htm
TRANSACTION IN OWN SHARES
a5087u
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
September,
2026
Commission File Number 001-10306
NatWest Group plc
250 Bishopsgate,
London, EC2M 4AA
United Kingdom
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F
☒
Form 40-F
☐
The
following information was issued as Company announcements in
London, England and is furnished pursuant to General Instruction B
to the General Instructions to Form 6-K:
NatWest Group plc
11 September 2026
Transaction in Own Shares
NatWest Group plc (the 'Company') announces that, over the past
week, it has purchased the following number of ordinary shares in
the Company with a nominal value of £1.0769* each ('Ordinary
Shares') from UBS AG, London Branch ('UBS').
Aggregated information:
Date of purchase
Number of Ordinary Shares purchased
Highest price paid: (GBp)
Lowest price paid: (GBp)
Volume weighted average price paid per share
(GBp)
Venue
08 September 2026
113,813
694.0000
688.40
690.8749
LSE
08 September 2026
25,163
692.0000
689.40
690.4149
CHIX
08 September 2026
11,864
692.0000
688.80
690.2854
BATE
09 September 2026
1,168,596
693.4000
681.40
685.9972
LSE
09 September 2026
281,543
693.6000
681.60
686.1804
CHIX
09 September 2026
130,751
691.6000
681.40
685.6657
BATE
10 September 2026
703,490
688.0000
679.60
683.2357
LSE
10 September 2026
161,844
686.0000
679.80
682.6652
CHIX
10 September 2026
77,828
686.0000
680.00
682.7273
BATE
* Note:
the
nominal value of Ordinary Shares without rounding is
£1.076923076923077 per share
Such purchases form part of the Company's existing share buyback
programme and were effected pursuant to the instructions issued by
the Company to UBS on 16 February 2026, as announced on 16 February
2026.
The Company intends to cancel the repurchased Ordinary
Shares.
Following the settlement of the above transactions, NWG will hold
178,291,235 Ordinary Shares in treasury and have 7,946,685,503
Ordinary Shares in issue (excluding treasury shares). The total
number of voting rights in the Company will be 31,788,674,572. This
figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, the
Company under the FCA's Disclosure Guidance and Transparency
Rules.
Further information:
Investor Relations
+ 44 (0)207 672 1758
Media Relations
+44 (0)131 523 4205
Legal Entity Identifier: 2138005O9XJIJN4JPN90
Transaction details:
In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014
as it applies in the UK (Market Abuse Regulation), a full breakdown
of the individual trades made by UBS on behalf of the Company as
part of the buyback programme relating to the Transactions is
detailed in the attached:
http://www.rns-pdf.londonstockexchange.com/rns/5076U_1-2026-9-11.pdf
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
NatWest Group plc
(Registrant)
Date:
11
September 2026
By:
/s/
Mark Stevens
Name:
Mark
Stevens
Title:
Assistant
Secretary
6-K
1
a5087u.htm
TRANSACTION IN OWN SHARES
a5087u
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
September,
2026
Commission File Number 001-10306
NatWest Group plc
250 Bishopsgate,
London, EC2M 4AA
United Kingdom
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F
☒
Form 40-F
☐
The
following information was issued as Company announcements in
London, England and is furnished pursuant to General Instruction B
to the General Instructions to Form 6-K:
NatWest Group plc
11 September 2026
Transaction in Own Shares
NatWest Group plc (the 'Company') announces that, over the past
week, it has purchased the following number of ordinary shares in
the Company with a nominal value of £1.0769* each ('Ordinary
Shares') from UBS AG, London Branch ('UBS').
Aggregated information:
Date of purchase
Number of Ordinary Shares purchased
Highest price paid: (GBp)
Lowest price paid: (GBp)
Volume weighted average price paid per share
(GBp)
Venue
08 September 2026
113,813
694.0000
688.40
690.8749
LSE
08 September 2026
25,163
692.0000
689.40
690.4149
CHIX
08 September 2026
11,864
692.0000
688.80
690.2854
BATE
09 September 2026
1,168,596
693.4000
681.40
685.9972
LSE
09 September 2026
281,543
693.6000
681.60
686.1804
CHIX
09 September 2026
130,751
691.6000
681.40
685.6657
BATE
10 September 2026
703,490
688.0000
679.60
683.2357
LSE
10 September 2026
161,844
686.0000
679.80
682.6652
CHIX
10 September 2026
77,828
686.0000
680.00
682.7273
BATE
* Note:
the
nominal value of Ordinary Shares without rounding is
£1.076923076923077 per share
Such purchases form part of the Company's existing share buyback
programme and were effected pursuant to the instructions issued by
the Company to UBS on 16 February 2026, as announced on 16 February
2026.
The Company intends to cancel the repurchased Ordinary
Shares.
Following the settlement of the above transactions, NWG will hold
178,291,235 Ordinary Shares in treasury and have 7,946,685,503
Ordinary Shares in issue (excluding treasury shares). The total
number of voting rights in the Company will be 31,788,674,572. This
figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, the
Company under the FCA's Disclosure Guidance and Transparency
Rules.
Further information:
Investor Relations
+ 44 (0)207 672 1758
Media Relations
+44 (0)131 523 4205
Legal Entity Identifier: 2138005O9XJIJN4JPN90
Transaction details:
In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014
as it applies in the UK (Market Abuse Regulation), a full breakdown
of the individual trades made by UBS on behalf of the Company as
part of the buyback programme relating to the Transactions is
detailed in the attached:
http://www.rns-pdf.londonstockexchange.com/rns/5076U_1-2026-9-11.pdf
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
NatWest Group plc
(Registrant)
Date:
11
September 2026
By:
/s/
Mark Stevens
Name:
Mark
Stevens
Title:
Assistant
Secretary
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。